Ambruzs JM, Walker PD, Larsen CP. The histopathologic spectrum of kidney biopsies in patients with inflammatory bowel disease. Clin J Am Soc Nephrol. 2014;9(2):265–70.

Article  PubMed  Google Scholar 

Nurmi R, Pohjonen J, Metso M, et al. Prevalence of inflammatory bowel disease and celiac disease in patients with IgA nephropathy over time. Nephron. 2021;145(1):78–84.

Article  CAS  PubMed  Google Scholar 

Rehnberg J, Symreng A, Ludvigsson JF, Emilsson L. Inflammatory bowel disease is more common in patients with IgA nephropathy and predicts progression of ESKD: a Swedish population-based cohort study. J Am Soc Nephrol. 2021;32(2):411–23.

Article  CAS  PubMed  Google Scholar 

Ueno Y, Tanaka S, Onitake T, et al. Infliximab treatment for Crohn’s disease in a patient with IgA nephropathy. Clin J Gastroenterol. 2009;2(6):380–3.

Article  PubMed  Google Scholar 

Singh AKB, Jeyaruban AS, Wilson GJ, Ranganathan D. Adalimumab-induced IgA nephropathy. BMJ Case Rep. 2019;12(3): e226442.

Article  Google Scholar 

Strobel T, Ahmed W, De la Sancha C, Bohm M, Fischer M. IgA nephropathy in the setting of anti-TNF-α therapy for inflammatory bowel disease. ACG Case Rep J. 2020;7(9): e00462.

Article  PubMed  PubMed Central  Google Scholar 

Mertelj T, Smrekar N, Kojc N, Lindič J, Kovač D. IgA nephropathy in a patient treated with adalimumab. Case Rep Nephrol Dial. 2021;11(2):233–40.

Article  PubMed  PubMed Central  Google Scholar 

Joher N, Gosset C, Guerrot D, et al. Immunoglobulin A nephropathy in association with inflammatory bowel diseases: results from a national study and systematic literature review. Nephrol Dial Transplant. 2022;37(3):531–9.

Article  CAS  PubMed  Google Scholar 

Pozzi C, Bolasco PG, Fogazzi G, et al. Corticosteroids in IgA nephropathy: a randomised controlled trial. Lancet. 1999;353(9156):883–7.

Article  CAS  PubMed  Google Scholar 

Atzeni F, Talotta R, Salaffi F, et al. Immunogenicity and autoimmunity during anti-TNF therapy. Autoimmun Rev. 2013;12(7):703–8.

Article  CAS  PubMed  Google Scholar 

Ramos-Casals M, Roberto-Perez-Alvarez, Diaz-Lagares C, Cuadrado MJ, Khamashta MA. Autoimmune diseases induced by biological agents. A double-edged sword? Autoimmun Rev. 2010;9(3):188–93.

Article  CAS  PubMed  Google Scholar 

Perez-Alvarez R, Pérez-De-Lis M, Ramos-Casals M. Biologics-induced autoimmune diseases. Curr Opin Rheumatol. 2013;25(1):56–64.

Article  CAS  PubMed  Google Scholar 

Marocchi E, Spadaro A, Giannakakis K, Priori R, Valesini G. Infliximab in a patient with ankylosing spondylitis and secondary IgA nephropathy requiring haemodialysis. Clin Exp Rheumatol. 2010;28(3):440.

PubMed  Google Scholar 

Wei SS, Sinniah R. Adalimumab (TNFα inhibitor) therapy exacerbates IgA glomerulonephritis acute renal injury and induces lupus autoantibodies in a psoriasis patient. Case Rep Nephrol. 2013. https://doi.org/10.1155/2013/812781.

Article  PubMed  PubMed Central  Google Scholar 

Kluger N, Du-Thanh A, Bessis D, Servel MF, Mourad G. Psoriasis-associated IgA nephropathy under infliximab therapy. Int J Dermatol. 2015;54(3):e79–80.

Article  CAS  PubMed  Google Scholar 

Jacquet A, Francois H, Frangie C, et al. IgA nephropathy associated with ankylosing spondylitis is not controlled by infliximab therapy. Nephrol Dial Transplant. 2009;24(11):3540–2.

Article  CAS  PubMed  Google Scholar 

Sakellariou GT, Vounotrypidis P, Berberidis C. Infliximab treatment in two patients with psoriatic arthritis and secondary IgA nephropathy. Clin Rheumatol. 2007;26(7):1132–3.

Article  PubMed  Google Scholar 

Premužić V, Padjen I, Cerovec M, Ćorić M, Jelaković B, Anić B. The association of TNF-alpha inhibitors and development of IgA nephropathy in patients with rheumatoid arthritis and diabetes. Case Rep Nephrol. 2020. https://doi.org/10.1155/2020/9480860.

Article  PubMed  PubMed Central  Google Scholar 

Segawa Y, Ishida R, Kanehisa F, et al. IgA nephropathy in a patient receiving infliximab for generalized pustular psoriasis. BMC Nephrol. 2020;21(1):1–6.

Article  Google Scholar 

Hayashi R, Ueno Y, Tanaka S, et al. Clinical characteristics of inflammatory bowel disease patients with immunoglobulin A nephropathy. Intest Res. 2021;19(4):430–7.

Article  PubMed  Google Scholar 

Lee M, Suzuki H, Kato R, et al. Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy. CEN Case Rep. 2021;10(1):17–22.

Article  CAS  PubMed  Google Scholar 

Rasmussen C, Abitbol V, El Karoui K, et al. IgA vasculitis in patients with inflammatory bowel disease: new insights into the role of TNF-α blockers. Rheumatology (Oxford). 2022;61(5):1957–65.

Article  CAS  PubMed  Google Scholar 

Sokumbi O, Wetter DA, Makol A, Warrington KJ. Vasculitis associated with tumor necrosis factor-α inhibitors. Mayo Clin Proc. 2012;87(8):739–45.

Article  PubMed  PubMed Central  Google Scholar 

Gisbert JP, Marín AC, Chaparro M. The risk of relapse after anti-TNF discontinuation in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol. 2016;111(5):632–47.

Article  CAS  PubMed  Google Scholar 

Song JH, Kang EA, Park SK, et al. Long-term outcomes after the discontinuation of anti-tumor necrosis factor-α therapy in patients with inflammatory bowel disease under clinical remission: a Korean association for the study of intestinal disease multicenter study. Gut Liver. 2021;15(5):752–62.

Article  PubMed  PubMed Central  Google Scholar 

Ruszkowski J, Lisowska KA, Pindel M, Heleniak Z, Dębska-Ślizień A, Witkowski JM. T cells in IgA nephropathy: role in pathogenesis, clinical significance and potential therapeutic target. Clin Exp Nephrol. 2019;23(3):291–303.

Article  CAS  PubMed  Google Scholar 

Leppkes M, Neurath MF. Cytokines in inflammatory bowel diseases - update 2020. Pharmacol Res. 2020;158: 104835.

Article  CAS  PubMed  Google Scholar 

Johnson RJ, Hurtado A, Merszei J, Rodriguez-Iturbe B, Feng L. Hypothesis: dysregulation of immunologic balance resulting from hygiene and socioeconomic factors may influence the epidemiology and cause of glomerulonephritis worldwide. Am J Kidney Dis. 2003;42(3):575–81.

Article  PubMed  Google Scholar 

Hirano K, Matsuzaki K, Yasuda T, et al. Association between tonsillectomy and outcomes in patients with immunoglobulin a nephropathy. JAMA Netw Open. 2019;2(5): e194772.

Article  PubMed  PubMed Central  Google Scholar 

He L, Peng Y, Liu H, et al. Th1/Th2 polarization in tonsillar lymphocyte form patients with IgA nephropathy. Ren Fail. 2014;36(3):407–12.

Article  CAS  PubMed  Google Scholar 

Piovani D, Danese S, Peyrin-Biroulet L, Nikolopoulos GK, Lytras T, Bonovas S. Environmental risk factors for inflammatory bowel diseases: an umbrella review of meta-analyses. Gastroenterology. 2019;157(3):647–59.

Article  PubMed  Google Scholar